Clinical trial
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study
NCT06603506 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study
- Lead sponsor
- Centre Francois Baclesse
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 21, 2024
- Completion date
- October 15, 2027
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer